• LAST PRICE
    1.7000
  • TODAY'S CHANGE (%)
    Trending Down-0.1700 (-9.0909%)
  • Bid / Lots
    1.6500/ 25
  • Ask / Lots
    1.7000/ 1
  • Open / Previous Close
    1.8800 / 1.8700
  • Day Range
    Low 1.6100
    High 1.9151
  • 52 Week Range
    Low 0.4500
    High 3.2491
  • Volume
    569,097
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 1.87
TimeVolumeCUE
09:32 ET63841.8202
09:33 ET2031.8652
09:37 ET10001.8422
09:39 ET117001.8433
09:42 ET23691.88
09:44 ET15001.8798
09:48 ET15621.9151
09:50 ET19851.9
09:51 ET164141.84
09:53 ET133161.85
09:55 ET1781.85
09:57 ET3081.84
10:02 ET1361.8626
10:06 ET245341.91
10:08 ET4001.895
10:13 ET59551.9096
10:15 ET53001.89
10:18 ET116001.9
10:20 ET4501.88
10:22 ET3501.88
10:24 ET2481.8847
10:31 ET1001.875
10:33 ET14181.875
10:36 ET4001.86
10:45 ET71761.82
10:49 ET7241.8202
10:51 ET27701.8294
10:54 ET81621.83
10:56 ET1001.82
10:58 ET23511.8283
11:00 ET33721.807623
11:02 ET1001.8
11:05 ET9671.77
11:07 ET1001.77
11:09 ET1001.77
11:12 ET9381.79
11:14 ET107541.79
11:16 ET554011.71
11:18 ET21001.7
11:21 ET1001.6911
11:23 ET7401.7175
11:25 ET50001.7001
11:27 ET33601.7096
11:30 ET65961.73
11:32 ET15291.7399
11:34 ET2001.74
11:36 ET45941.76
11:43 ET7921.75
11:48 ET7931.764
11:50 ET1411.7685
11:56 ET1291.7565
11:57 ET2161.7551
12:01 ET7521.76
12:03 ET2191.75
12:06 ET5701.75
12:08 ET3001.765
12:14 ET45941.78
12:15 ET18821.76
12:17 ET4491.77
12:19 ET21001.784
12:21 ET15001.8
12:24 ET25451.8
12:26 ET5001.786781
12:28 ET6001.7801
12:30 ET1001.8
12:35 ET5831.7985
12:37 ET30001.819
12:39 ET2001.82
12:42 ET56001.82
12:46 ET13001.82
12:48 ET8091.8285
12:51 ET1001.815
12:53 ET23321.8229
12:55 ET1001.8046
12:57 ET1001.815
01:02 ET41851.8003
01:09 ET2001.7901
01:20 ET3001.82
01:24 ET15181.8
01:26 ET4001.8199
01:58 ET1001.79
02:00 ET2001.799
02:07 ET11051.8089
02:09 ET36021.7891
02:12 ET2001.79
02:16 ET40361.788
02:25 ET2001.79
02:39 ET1001.8
02:41 ET12521.7845
02:45 ET22001.79
02:48 ET28301.7999
02:50 ET53281.8291
02:52 ET59651.83
02:54 ET23701.83
02:56 ET30001.84
02:59 ET13471.84
03:03 ET4001.84
03:08 ET2001.82
03:14 ET3001.83
03:24 ET2001.79
03:30 ET2001.78
03:32 ET16731.79
03:35 ET33961.79
03:42 ET8921.79
03:44 ET6001.79
03:46 ET32621.8
03:48 ET87661.81
03:50 ET24301.81
03:51 ET106371.825
03:53 ET41361.82
03:55 ET608181.75
03:57 ET442561.67
04:00 ET913161.7
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCUE
Cue Biopharma Inc
102.4M
-1.7x
---
United StatesANL
Adlai Nortye Ltd
114.8M
-0.5x
---
United StatesCOYA
Coya Therapeutics Inc
121.1M
-9.4x
---
United StatesASMB
Assembly Biosciences Inc
105.3M
-2.2x
---
United StatesCRVO
CervoMed Inc
97.6M
-24.7x
---
United StatesIPSC
Century Therapeutics Inc
119.9M
-0.8x
---
As of 2024-11-13

Company Information

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate disease-specific T cells. The Company's platform, Immuno-STAT (Selective Targeting and Alteration of T cells) and biologics are designed to harness the curative potential of the body's intrinsic immune system through the selective modulation of disease-specific T cells without the adverse effects of broad systemic immune modulation. Its two oncology drug product candidates, CUE-101 and CUE-102, are exemplary programs from the interleukin 2 (IL-2) based CUE-100 series, and are representative of the HLA-A02 allele, which is prevalent in the United States and western European territories. CUE-101 HLA-A02 is engineered for the treatment of human papillomavirus positive, head and neck squamous cell carcinoma (HNSCC). CUE-102 HLA-A02, targeting Wilms' Tumor 1 protein, an oncofetal antigen known to be over-expressed in more than 20 different cancers.

Contact Information

Headquarters
40 Guest StreetBOSTON, MA, United States 02135
Phone
617-949-2680
Fax
302-655-5049

Executives

Independent Chairman of the Board
Frank Morich
President, Chief Scientific Officer
Anish Suri
Chief Executive Officer, Director
Daniel Passeri
Chief Financial Officer
Kerri-Ann Millar
Senior Vice President, General Counsel, Secretary
Colin Sandercock

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$112.6M
Revenue (TTM)
$8.3M
Shares Outstanding
60.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.77
EPS
$-0.97
Book Value
$0.79
P/E Ratio
-1.7x
Price/Sales (TTM)
13.6
Price/Cash Flow (TTM)
---
Operating Margin
-582.23%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.